# Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH

> **NCT04555434** · PHASE1,PHASE2 · COMPLETED · sponsor: **Chuncheon Sacred Heart Hospital** · enrollment: 89 (actual)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease
- MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotics

## Key facts

- **NCT ID:** NCT04555434
- **Lead sponsor:** Chuncheon Sacred Heart Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-20
- **Primary completion:** 2022-09-11
- **Final completion:** 2025-12-01
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04555434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04555434, "Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04555434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*